Westwood Holdings Group Inc Caribou Biosciences, Inc. Transaction History

Westwood Holdings Group Inc

  • $12.6 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$4.82 - $8.26 $124,057 - $212,595
-25,738 Reduced 9.28%
251,467 $1.29 Million
Q4 2023

Feb 13, 2024
BUY
$3.58 - $6.25 $446,673 - $779,806
124,769 Added 81.85%
277,205 $1.59 Million
Q3 2023

Nov 14, 2023
BUY
$4.08 - $8.14 $621,938 - $1.24 Million
152,436 New
152,436 $729,000

Others Institutions Holding CRBU

# of Institutions
135
Shares Held
52.6M
Call Options Held
148K
Put Options Held
70.7K
View Full List

About Caribou Biosciences, Inc.

CRBU Quotes by TradingView
  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $123M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track Westwood Holdings Group Inc Portfolio

Follow Westwood Holdings Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westwood Holdings Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Westwood Holdings Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email